… and subcutaneous tissue of obese patients undergoing bariatric surgery, compared with a
… were distinctly lower in the obese group than in the non-obese group, but decreased more …

… ) (subcutaneous tissue concentration of cefazolin above the … Bariatric surgery is offered to
overweight patients to reduce … Moreover, this model included obese and non-obese patients, …

… The optimal IV dose for skin and soft tissue infections in patients with normal renal …
cefazolin concentrations, but significantly lower unbound cefazolin ISF in obese versus non-obese …

… reduced cefazolin subcutaneous tissue concentrations, data regarding subcutaneous fatty-tissue
concentrations in severely obese … In a retrospective cohort study, obese and non-obese …

… Some studies carried out during surgery, however, question the adequacy of this dose in
obese patients since CFZ distribution to subcutaneous tissue is reduced in morbidly obese …

… /tazobactam, fosfomcyine, cefazolin, metronidazole and as … /m 2 for obese or between 18.5
and 30 kg/m 2 for non-obese … cut-off 20,000 Da, CMA, Kista, Sweden) were placed into the …

… of surgical patients were only marginally different between obese and non-obese patients,
the drug exposure in subcutaneous tissue was significantly lower in the obese patients. …

… women are at greater risk for infection than non-obese … Two adipose samples were
collected from subcutaneous tissue, 1 … However, following observation of decreasing cefazolin …

… of distribution of cefazolin increases, resulting in a decrease in … of cefazolin commonly
observed among obese patients … concentrations, irrespective of BMI, among morbidly obese …

… the recommended dose or weight or BMI cut-off values [6, 7]. … of cefazolin may be inadequate
in morbidly obese patients … SSI prevalence between obese and non-obese patients, or …